KEPIVANCE Side Effects

6417351-1 | Convulsion, Haemoglobin Decreased, Off Label Use, Rash, Stem Cell Transplant
on Oct 09, 2009 Female patient from UNITED KINGDOM , weighting 12.13 lb, was diagnosed with autoimmune disorder and was treated with Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, haemoglobin decreased, off label use, rash (What is rash?), stem cell transplant. Kepivance dosage: (60 Mcg/kg). During the same period patient was treated with TREOSULFAN (View Treosulfan Review and Treosulfan Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ), CODEINE (View Codeine Review and Codeine Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), AMBISOME (View Ambisome Review and Ambisome Label ), CETIRIZINE (View Cetirizine Review and Cetirizine Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ).

6341892-9 | Convulsion, Off Label Use, Rash, Stem Cell Transplant
Patient was taking Kepivance (View Usage). Patient had the following side effects: convulsion, off label use, rash (What is rash?), stem cell transplant on Aug 18, 2009 from UNITED KINGDOM Additional patient health information: Female patient , weighting 12.13 lb, was diagnosed with autoimmune disorder and. Kepivance dosage: (60 Mcg/kg). During the same period patient was treated with TREOSULFAN (View Treosulfan Review and Treosulfan Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ), CODEINE SULFATE (View Codeine Sulfate Review and Codeine Sulfate Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), AMBISOME (View Ambisome Review and Ambisome Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ).

6175664-5 | Exfoliative Rash
Adverse event was reported on Apr 14, 2009 by a Female patient taking Kepivance (View Usage) (Dosage: (60 Mcg/kg Qd Before Commencement Of The Conditioning Regimen), (60 Mcg/kg Qd After Stem Cell Infus) was diagnosed with mucosal inflammation and. Location: AUSTRALIA , 59 years of age, After Kepivance was administered, patient had the following side effects: exfoliative rash. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), BUSULPHAN () (View Busulphan () Review and Busulphan () Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6102202-5 | Cell Marker Increased, Lichen Planus, Oral Mucosal Eruption, Rash Papular
on Feb 23, 2009 Male patient from UNITED STATES , 70 years of age, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: cell marker increased, lichen planus, oral mucosal eruption, rash papular. Kepivance dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), DECADRON (View Decadron Review and Decadron Label ), HEMATOPOETIC PROGENITOR CELLS HUMAN (View Hematopoetic Progenitor Cells Human Review and Hematopoetic Progenitor Cells Human Label ).


5916454-5 | Eyelid Oedema, Face Oedema, Pharyngeal Oedema
on Oct 06, 2008 Male patient from GREECE , weighting 147.7 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Kepivance (View Usage). Patient had the following side effects: eyelid oedema, face oedema, pharyngeal oedema. Kepivance dosage: . During the same period patient was treated with ZOVIRAX (View Zovirax Review and Zovirax Label ), REMERON (View Remeron Review and Remeron Label ), GRANOCYTE (View Granocyte Review and Granocyte Label ), EMEND (View Emend Review and Emend Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

5910962-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Patient was taking Kepivance (View Usage). After Kepivance was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased on Oct 03, 2008 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 134.5 lb, . Kepivance dosage: 3720 Mcg Q24hours For 3 Days Iv. Patient was hospitalized.

5892157-0 | Aplasia, Face Oedema, Gastrointestinal Inflammation, Oedema Peripheral, Pyrexia, Skin Reaction, Stomatitis
Adverse event was reported on Sep 15, 2008 by a Female patient taking Kepivance (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: FRANCE , 56 years of age, Patient experienced the following unwanted or unexpected effects: aplasia, face oedema, gastrointestinal inflammation, oedema peripheral, pyrexia, skin reaction, stomatitis. During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PLATELETS (View Platelets Review and Platelets Label ). Patient was hospitalized.

5862820-6 | Aplasia, Face Oedema, Gastrointestinal Inflammation, Oedema Peripheral, Skin Reaction, Stomatitis, Toxic Skin Eruption
on Aug 18, 2008 Female patient from FRANCE , 56 years of age, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). Patient had the following side effects: aplasia, face oedema, gastrointestinal inflammation, oedema peripheral, skin reaction, stomatitis, toxic skin eruption. Kepivance dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PLATELETS (View Platelets Review and Platelets Label ).

5833626-9 | Chills, Erythema, Flushing, Prurigo, Pruritus, Purpura, Pyrexia, Rash, Rash Maculo-papular
on Jul 24, 2008 Female patient from FRANCE , 59 years of age, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). After Kepivance was administered, patient had the following side effects: chills, erythema, flushing, prurigo, pruritus, purpura, pyrexia, rash (What is rash?), rash maculo-papular. Kepivance dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), MESNA (View Mesna Review and Mesna Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ). Patient was hospitalized.

5830351-5 | Aplasia, Face Oedema, Oedema Peripheral, Skin Reaction, Toxic Skin Eruption, Vomiting
Patient was taking Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: aplasia, face oedema, oedema peripheral, skin reaction, toxic skin eruption, vomiting on Jul 24, 2008 from FRANCE Additional patient health information: Female patient , 56 years of age, was diagnosed with mucosal inflammation and. Kepivance dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PLATELETS (View Platelets Review and Platelets Label ).

5822804-0 | Rash Erythematous, Rash Macular
Adverse event was reported on Jul 17, 2008 by a Male patient taking Kepivance (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: SPAIN , 57 years of age, Patient had the following side effects: rash erythematous, rash macular.

5808587-9 | Face Oedema, Pyrexia, Rash, Stomatitis
on Jul 04, 2008 Male patient from BELGIUM , weighting 134.5 lb, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). After Kepivance was administered, patient had the following side effects: face oedema, pyrexia, rash (What is rash?), stomatitis. Kepivance dosage: . During the same period patient was treated with MYLERAN (View Myleran Review and Myleran Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ). Patient was hospitalized.

5807966-3 | Face Oedema, Oedema Peripheral, Skin Reaction, Toxic Skin Eruption
on Jun 26, 2008 Female patient from FRANCE , 56 years of age, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, oedema peripheral, skin reaction, toxic skin eruption. Kepivance dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ).

5807965-1 | Chills, Flushing, Pyrexia, Rash, Rash Maculo-papular, Toxic Skin Eruption, Vasculitis
Patient was taking Kepivance (View Usage). Patient had the following side effects: chills, flushing, pyrexia, rash (What is rash?), rash maculo-papular, toxic skin eruption, vasculitis (What is vasculitis?) on Jun 26, 2008 from FRANCE Additional patient health information: Female patient , 59 years of age, was diagnosed with mucosal inflammation and. Kepivance dosage: . During the same period patient was treated with CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), MELPHALAN (View Melphalan Review and Melphalan Label ). Patient was hospitalized.

5806376-2 | Cardiac Failure, Cardiac Failure Acute, Cardiogenic Shock, Renal Failure Acute, Sepsis
Adverse event was reported on Jul 02, 2008 by a Female patient taking Kepivance (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: BELGIUM , weighting 147.7 lb, After Kepivance was administered, patient had the following side effects: cardiac failure, cardiac failure acute, cardiogenic shock, renal failure acute, sepsis (What is sepsis?). During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), HEPARIN (View Heparin Review and Heparin Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), PENTAMIDINE (View Pentamidine Review and Pentamidine Label ).

5799981-3 | Anorexia, Fatigue
on Jun 26, 2008 Male patient from BELGIUM , weighting 122.4 lb, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, fatigue. Kepivance dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), FILGRASTIM (View Filgrastim Review and Filgrastim Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ). Patient was hospitalized.

5793922-0 | Face Oedema, Pyrexia, Rash, Stomatitis
on Jun 18, 2008 Male patient from BELGIUM , weighting 134.5 lb, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). Patient had the following side effects: face oedema, pyrexia, rash (What is rash?), stomatitis. Kepivance dosage: . During the same period patient was treated with MYLERAN (View Myleran Review and Myleran Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ). Patient was hospitalized.

5793491-5 | Bronchopulmonary Aspergillosis, Epidermolysis, Fluid Overload, Shock
Patient was taking Kepivance (View Usage). After Kepivance was administered, patient had the following side effects: bronchopulmonary aspergillosis, epidermolysis, fluid overload, shock on Jun 17, 2008 from BELGIUM Additional patient health information: Male patient , weighting 145.5 lb, was diagnosed with mucosal inflammation and. Kepivance dosage: . Patient was hospitalized.

5754302-7 | Face Oedema, Pyrexia, Rash, Stomatitis
Adverse event was reported on May 22, 2008 by a Male patient taking Kepivance (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: BELGIUM , weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: face oedema, pyrexia, rash (What is rash?), stomatitis. During the same period patient was treated with ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), MYLERAN (View Myleran Review and Myleran Label ).

5751300-4 | Cardiac Failure, Cardiac Failure Acute, Cardiogenic Shock, Renal Failure Acute, Sepsis
on May 19, 2008 Female patient from BELGIUM , weighting 147.7 lb, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). Patient had the following side effects: cardiac failure, cardiac failure acute, cardiogenic shock, renal failure acute, sepsis (What is sepsis?). Kepivance dosage: . During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), HEPARIN (View Heparin Review and Heparin Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), PENTAMIDINE (View Pentamidine Review and Pentamidine Label ).

5748083-0 | Anorexia, Gastrointestinal Inflammation, Mucosal Infection, Stomatitis
on May 16, 2008 Female patient from BELGIUM , weighting 136.7 lb, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). After Kepivance was administered, patient had the following side effects: anorexia, gastrointestinal inflammation, mucosal infection, stomatitis. Kepivance dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ). Patient was hospitalized.

5748009-X | Anorexia, Fatigue
Patient was taking Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, fatigue on May 16, 2008 from BELGIUM Additional patient health information: Male patient , weighting 122.4 lb, was diagnosed with mucosal inflammation and. Kepivance dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), FILGRASTIM (View Filgrastim Review and Filgrastim Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ). Patient was hospitalized.

5727442-6 | Face Oedema, Pyrexia, Rash, Stomatitis
Adverse event was reported on Apr 25, 2008 by a Male patient taking Kepivance (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: BELGIUM , weighting 134.5 lb, Patient had the following side effects: face oedema, pyrexia, rash (What is rash?), stomatitis. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ). Patient was hospitalized.

5725076-0 | Mouth Haemorrhage, Oropharyngeal Blistering, Platelet Count Decreased
on Apr 18, 2008 Female patient from UNITED STATES , 37 years of age, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). After Kepivance was administered, patient had the following side effects: mouth haemorrhage, oropharyngeal blistering, platelet count decreased. Kepivance dosage: . During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ). Patient was hospitalized.

5724176-9 | Periorbital Oedema, Pruritus, Rash
on Apr 17, 2008 Female patient from GERMANY , weighting 127.9 lb, was treated with Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: periorbital oedema, pruritus, rash (What is rash?). Kepivance dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), MELPHALAN (View Melphalan Review and Melphalan Label ).

5709488-7 | Face Oedema, Pyrexia, Rash, Stomatitis
Patient was taking Kepivance (View Usage). Patient had the following side effects: face oedema, pyrexia, rash (What is rash?), stomatitis on Apr 08, 2008 from BELGIUM Additional patient health information: Male patient , weighting 134.5 lb, was diagnosed with mucosal inflammation and. Kepivance dosage: . During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ). Patient was hospitalized.

5709407-3 | Anorexia, Fatigue
Adverse event was reported on Apr 08, 2008 by a Male patient taking Kepivance (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: BELGIUM , weighting 122.4 lb, After Kepivance was administered, patient had the following side effects: anorexia, fatigue. During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ). Patient was hospitalized.

5706065-9 | Anorexia, Gastrointestinal Inflammation, Mucosal Infection, Stomatitis
on Apr 03, 2008 Female patient from BELGIUM , weighting 136.7 lb, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, gastrointestinal inflammation, mucosal infection, stomatitis. Kepivance dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ). Patient was hospitalized.

5675665-7 | Periorbital Oedema, Pruritus, Rash
on Mar 10, 2008 Female patient from GERMANY , weighting 127.9 lb, was treated with Kepivance (View Usage). Patient had the following side effects: periorbital oedema, pruritus, rash (What is rash?). Kepivance dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

5657172-0 | Epidermolysis
Patient was taking Kepivance (View Usage). After Kepivance was administered, patient had the following side effects: epidermolysis on Feb 26, 2008 from GERMANY Additional patient health information: Female patient , weighting 132.3 lb, was diagnosed with mucosal inflammation and. Kepivance dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), TAVEGIL (View Tavegil Review and Tavegil Label ), TAGAMET (View Tagamet Review and Tagamet Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), MESNA (View Mesna Review and Mesna Label ).

5657169-0 | Epidermolysis, Petechiae
Adverse event was reported on Feb 26, 2008 by a Female patient taking Kepivance (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: GERMANY , weighting 178.6 lb, Patient experienced the following unwanted or unexpected effects: epidermolysis, petechiae. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), VINDESINE (View Vindesine Review and Vindesine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VP 16 (View Vp-16 Review and Vp-16 Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ).

5643487-9 | Periorbital Oedema, Pruritus, Rash
on Feb 15, 2008 Female patient from GERMANY , weighting 127.9 lb, was treated with Kepivance (View Usage). Patient had the following side effects: periorbital oedema, pruritus, rash (What is rash?). Kepivance dosage: .

5637184-3 | Cardiac Arrest, Cardiac Failure, Hypersensitivity
on Feb 11, 2008 Female patient from BELGIUM , weighting 142.2 lb, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). After Kepivance was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), cardiac failure, hypersensitivity. Kepivance dosage: . During the same period patient was treated with CARMUSTINE (View Carmustine Review and Carmustine Label ), TAVANIC (View Tavanic Review and Tavanic Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ).

5605968-3 | Salivary Hypersecretion
Patient was taking Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: salivary hypersecretion on Oct 19, 2007 from UNITED STATES Additional patient health information: Female patient , 56 years of age, was diagnosed with bone marrow transplant (What is bone marrow transplant?) and. Kepivance dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ).

5595036-1 | Rash Erythematous, Rash Macular
Adverse event was reported on Jan 08, 2008 by a Male patient taking Kepivance (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: SPAIN , 57 years of age, Patient had the following side effects: rash erythematous, rash macular.

5573643-X | Face Oedema, Oedema Peripheral, Pruritus
on Dec 13, 2007 Female patient from SPAIN , 41 years of age, was treated with Kepivance (View Usage). After Kepivance was administered, patient had the following side effects: face oedema, oedema peripheral, pruritus. Kepivance dosage: .

5517382-X | Rash, Renal Failure Acute
on Nov 01, 2007 Female patient from GREECE , 59 years of age, was diagnosed with bone marrow transplant (What is bone marrow transplant?) and was treated with Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?), renal failure acute. Kepivance dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), ABELCET (View Abelcet Review and Abelcet Label ). Patient was hospitalized.

5517371-5 | Dysgeusia, Rash, Tongue Disorder
Patient was taking Kepivance (View Usage). Patient had the following side effects: dysgeusia, rash (What is rash?), tongue disorder on Nov 01, 2007 from GREECE Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with peripheral blood stem cell apheresis and. Kepivance dosage: . During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

5517370-3 | Choking Sensation, Epiglottic Oedema, Erythema, Oedema Peripheral, Tongue Oedema
Adverse event was reported on Nov 01, 2007 by a Male patient taking Kepivance (View Usage) (Dosage: ) was diagnosed with pre-existing disease and. Location: GREECE , weighting 127.9 lb, After Kepivance was administered, patient had the following side effects: choking sensation, epiglottic oedema, erythema, oedema peripheral, tongue oedema. During the same period patient was treated with ANTIBIOTICS NOS (View Antibiotics Nos Review and Antibiotics Nos Label ).

5517369-7 | Erythema
on Nov 01, 2007 Male patient from GREECE , weighting 231.5 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: erythema. Kepivance dosage: .

5517367-3 | Rash
on Nov 01, 2007 Male patient from GREECE , weighting 213.8 lb, was diagnosed with bone marrow transplant (What is bone marrow transplant?) and was treated with Kepivance (View Usage). Patient had the following side effects: rash (What is rash?). Kepivance dosage: . During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

5482267-4 | Acute Pulmonary Oedema, Acute Respiratory Distress Syndrome, Pericardial Effusion, Pericarditis, Pleural Effusion
Patient was taking Kepivance (View Usage). After Kepivance was administered, patient had the following side effects: acute pulmonary oedema, acute respiratory distress syndrome, pericardial effusion, pericarditis, pleural effusion on Oct 04, 2007 from FRANCE Additional patient health information: Female patient , 38 years of age, weighting 116.8 lb, . Kepivance dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), THYMOGLOBULIN (View Thymoglobulin Review and Thymoglobulin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

5481373-8 | Chills, Dyspnoea, Hypoaesthesia, Pyrexia, Sepsis
Adverse event was reported on Oct 02, 2007 by a Male patient taking Kepivance (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: AUSTRALIA , weighting 183.0 lb, Patient experienced the following unwanted or unexpected effects: chills, dyspnoea, hypoaesthesia, pyrexia, sepsis (What is sepsis?). During the same period patient was treated with CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5478640-0 | Blister, Dysaesthesia, Dysgeusia, Erectile Dysfunction, Erythema, Fatigue, Hypertension, Oedema Peripheral
on Sep 06, 2007 Male patient from GERMANY , weighting 211.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). Patient had the following side effects: blister, dysaesthesia, dysgeusia, erectile dysfunction (What is erectile dysfunction?), erythema, fatigue, hypertension, oedema peripheral. Kepivance dosage: . During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), CORTISONE ACETATE TAB (View Cortisone Acetate Tab Review and Cortisone Acetate Tab Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5470813-6 | Chills, Dyspnoea, Hypoaesthesia, Pyrexia, Sepsis
on Sep 19, 2007 Male patient from AUSTRALIA , weighting 183.0 lb, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). After Kepivance was administered, patient had the following side effects: chills, dyspnoea, hypoaesthesia, pyrexia, sepsis (What is sepsis?). Kepivance dosage: . During the same period patient was treated with CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5469751-4 | Anorexia, Diarrhoea, Febrile Neutropenia, Gastritis, Hypoalbuminaemia, Lung Infiltration, Mouth Haemorrhage, Oesophagitis, Sepsis
Patient was taking Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, diarrhoea, febrile neutropenia, gastritis, hypoalbuminaemia, lung infiltration, mouth haemorrhage, oesophagitis, sepsis (What is sepsis?) on Sep 18, 2007 from BELGIUM Additional patient health information: Female patient , weighting 132.3 lb, was diagnosed with mucosal inflammation and. Kepivance dosage: . During the same period patient was treated with TEMESTA (View Temesta Review and Temesta Label ), ZESTRIL (View Zestril Review and Zestril Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), ZOFRAN (View Zofran Review and Zofran Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ). Patient was hospitalized.

5444521-1 | Chills, Dyspnoea, Hypoaesthesia, Pyrexia, Sepsis
Adverse event was reported on Aug 23, 2007 by a Male patient taking Kepivance (View Usage) (Dosage: ) was diagnosed with mucosal inflammation and. Location: AUSTRALIA , weighting 183.0 lb, Patient had the following side effects: chills, dyspnoea, hypoaesthesia, pyrexia, sepsis (What is sepsis?). Patient was hospitalized.

5416686-9 | Anorexia, Diarrhoea, Febrile Neutropenia, Gastritis, Hypoalbuminaemia, Lung Infiltration, Mouth Haemorrhage, Oesophagitis, Sepsis
on Aug 07, 2007 Female patient from BELGIUM , weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance (View Usage). After Kepivance was administered, patient had the following side effects: anorexia, diarrhoea, febrile neutropenia, gastritis, hypoalbuminaemia, lung infiltration, mouth haemorrhage, oesophagitis, sepsis (What is sepsis?). Kepivance dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ZESTRIL (View Zestril Review and Zestril Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), ZOFRAN (View Zofran Review and Zofran Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ). Patient was hospitalized.

5411565-5 | Acute Pulmonary Oedema, Acute Respiratory Distress Syndrome, Pericardial Effusion, Pericarditis, Pleural Effusion
on Aug 02, 2007 Female patient from FRANCE , 38 years of age, weighting 116.8 lb, was treated with Kepivance (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, acute respiratory distress syndrome, pericardial effusion, pericarditis, pleural effusion. Kepivance dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), THYMOGLOBULIN (View Thymoglobulin Review and Thymoglobulin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

5393696-1 | Anorexia, Diarrhoea, Febrile Neutropenia, Gastritis, Hypoalbuminaemia, Lung Infiltration, Mouth Haemorrhage, Oesophagitis, Sepsis
Patient was taking Kepivance (View Usage). Patient had the following side effects: anorexia, diarrhoea, febrile neutropenia, gastritis, hypoalbuminaemia, lung infiltration, mouth haemorrhage, oesophagitis, sepsis (What is sepsis?) on Jul 11, 2007 from BELGIUM Additional patient health information: Female patient , weighting 132.3 lb, was diagnosed with mucosal inflammation and. Kepivance dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ZESTRIL (View Zestril Review and Zestril Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), ZOFRAN (View Zofran Review and Zofran Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ). Patient was hospitalized.